How are claims with multiple sequences treated under MPEP 2434?

How are claims with multiple sequences treated under MPEP 2434?

According to MPEP 2434, claims containing multiple sequences are treated as follows:

Direct quote: “If the application contains a claim directed to a nucleotide sequence that is set forth by SEQ ID NO, and the claim recites a specific limitation of the sequence or variants thereof, the claim should be examined.”

This means that if a claim includes multiple sequences, each with a specific SEQ ID NO and accompanying limitations, the examiner should review each sequence individually. The examination process focuses on ensuring that each claimed sequence meets the patentability requirements, including novelty, non-obviousness, and adequate written description.

To learn more:

• multiple sequences
• SEQ ID NO
• claim examination
• nucleotide sequences